Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ResMed Inc (NYSE:RMD)

57.88
Delayed Data
As of Feb 12
 +0.76 / +1.33%
Today’s Change
48.99
Today|||52-Week Range
75.33
+7.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$8.1B

Company Description

ResMed, Inc. engages in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders. Its developing products with a focus on sleep-disordered breathing, or SDB. SDB includes obstructive sleep apnea, or OSA, and other respiratory disorders that occur during sleep. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Contact Information

ResMed, Inc.
9001 Spectrum Center Boulevard
San Diego California 92123
P:(858) 836-5000
Investor Relations:
(858) 836-5971

Employees

Shareholders

Mutual fund holders35.73%
Other institutional27.27%
Individual stakeholders1.85%

Top Executives

Michael J. FarrellChief Executive Officer & Director
Robert Andrew DouglasPresident & Chief Operating Officer
Brett A. SandercockChief Financial Officer
Frank LacagninaChief Information Officer
David PendarvisSecretary & Chief Administrative Officer